Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease …
Objectives: We aimed to test whether cilostazol has beneficial effects in the real-world
patients treated with intracoronary drug-eluting stents (DES). Background: The addition of …
patients treated with intracoronary drug-eluting stents (DES). Background: The addition of …
The role of molecular biology in the biomonitoring of human exposure to chemicals
B Muñoz, A Albores - International journal of molecular sciences, 2010 - mdpi.com
Exposure to different substances in an occupational environment is of utmost concern to
global agencies such as the World Health Organization and the International Labour …
global agencies such as the World Health Organization and the International Labour …
[HTML][HTML] Targeting gene therapies enhance sensitivity to chemo-and radiotherapy of human oral squamous cell carcinoma
H Tanzawa, K Uzawa, A Kasamatsu… - Oral Science …, 2015 - Elsevier
We have developed two methods to enhance the sensitivity of chemo-and/or radioresistant
oral squamous carcinoma cells (OSCC). One is a method to inhibit a chemoresistant gene …
oral squamous carcinoma cells (OSCC). One is a method to inhibit a chemoresistant gene …
Inhibitory effects of cilostazol on proliferation of vascular smooth muscle cells (VSMCs) through suppression of the ERK1/2 pathway
AR Yoo, SH Koh, GW Cho, SH Kim - Journal of Atherosclerosis and …, 2010 - jstage.jst.go.jp
Aim: The abnormal proliferation of vascular smooth muscle cells (VSMCs) in arterial walls is
an important pathogenic factor of vascular disorders such as atherosclerosis and restenosis …
an important pathogenic factor of vascular disorders such as atherosclerosis and restenosis …
Targeting phosphodiesterase 3 B enhances cisplatin sensitivity in human cancer cells
K Uzawa, A Kasamatsu, T Baba, K Usukura… - Cancer …, 2013 - Wiley Online Library
We previously reported that human squamous cell carcinoma (SCC) cell lines refractory to
cis‐diaminedichloro‐platinum II (cisplatin [CDDP]) had significant upregulation of the …
cis‐diaminedichloro‐platinum II (cisplatin [CDDP]) had significant upregulation of the …
The phosphodiesterase 3 inhibitor cilostazol does not stimulate growth of colorectal liver metastases after major hepatectomy
MJ Strowitzki, S Dold, M von Heesen, C Körbel… - Clinical & experimental …, 2014 - Springer
Liver failure after extended hepatectomy represents a major challenge in the surgery of
hepatic colorectal metastasis. A previous study has indicated that inhibition of …
hepatic colorectal metastasis. A previous study has indicated that inhibition of …
Wirkung des Phosphodiesterase-3-Hemmers Cilostazol auf die Heilung von Kolonanastomosen in der Ratte
CC Hübner - 2019 - publikationen.sulb.uni-saarland.de
In der Kolonchirurgie ist die Anastomoseninsuffizienz eine häufige postoperative
Komplikation und führt zu einer erhöhten Morbidität und Mortalität. Systemische und lokale …
Komplikation und führt zu einer erhöhten Morbidität und Mortalität. Systemische und lokale …
[PDF][PDF] Die Wirkung des Phosphodiesterase-3-Inhibitors Cilostazol auf das Tumorwachstum von kolorektalen Lebermetastasen nach ausgedehnter Leberteilresektion
MJ Strowitzki - 2014 - publikationen.sulb.uni-saarland.de
Das kolorektale Karzinom gehört zu den häufigsten Tumorerkrankungen in Deutschland.
Jährlich werden etwa 65.000 Neuerkrankungen dokumentiert. Häufig entwickeln sich im …
Jährlich werden etwa 65.000 Neuerkrankungen dokumentiert. Häufig entwickeln sich im …